Pathogenesis of Alcoholic Fatty Liver a Narrative Review

被引:13
作者
Seitz, Helmut K. [1 ]
Moreira, Bernardo [1 ]
Neuman, Manuela G. [2 ]
机构
[1] Heidelberg Univ, Ethianum Clin, Fac Med, Ctr Liver & Alcohol Associated Dis, D-69120 Heidelberg, Germany
[2] Univ Toronto, Temer Fac Med, Dept Pharmacol & Toxicol, In Vitro Drug Safety & Biotechnol,Banting Inst, Toronto, ON M5G OA3, Canada
来源
LIFE-BASEL | 2023年 / 13卷 / 08期
关键词
alcoholic fatty liver; adenosine monophosphate activated kinase; sterol regulatory element binding protein 1c; peroxisome proliferator activated receptor alpha; oxidative stress; OXIDATIVE STRESS; INTESTINAL PERMEABILITY; CYTOCHROME P4502E1; ETHANOL-METABOLISM; GUT MICROBIOTA; KNOCKOUT MICE; DISEASE; INJURY; CYP2E1; WINE;
D O I
10.3390/life13081662
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Alcohol effect hepatic lipid metabolism through various mechanisms, leading synergistically to an accumulation of fatty acids (FA) and triglycerides. Obesity, as well as dietary fat (saturated fatty acids (FA) versus poly-unsaturated fatty acids (PUFA)) may modulate the hepatic fat. Alcohol inhibits adenosine monophosphate activated kinase (AMPK). AMPK activates peroxisome proliferator activated receptor a (PPAR alpha) and leads to a decreased activation of sterol regulatory element binding protein 1c (SRABP1c). The inhibition of AMPK, and thus of PPAR alpha, results in an inhibition of FA oxidation. This ss-oxidation is further reduced due to mitochondrial damage induced through cytochrome P4502E1 (CYP2E1)-driven oxidative stress. Furthermore, the synthesis of FAs is stimulated through an activation of SHREP1. In addition, alcohol consumption leads to a reduced production of adiponectin in adipocytes due to oxidative stress and to an increased mobilization of FAs from adipose tissue and from the gut as chylomicrons. On the other side, the secretion of FAs via very-low-density lipoproteins (VLDL) from the liver is inhibited by alcohol. Alcohol also affects signal pathways such as early growth response 1 (Egr-1) associated with the expression of tumour necrosis factor alpha (TNF alpha), and the mammalian target of rapamycin (mTOR) a key regulator of autophagy. Both have influence the pathogenesis of alcoholic fatty liver. Alcohol-induced gut dysbiosis contributes to the severity of ALD by increasing the metabolism of ethanol in the gut and promoting intestinal dysfunction. Moreover, pathogen-associated molecular patterns (PAMPS) via specific Toll-like receptor (TLR) bacterial overgrowth leads to the translocation of bacteria. Endotoxins and toxic ethanol metabolites enter the enterohepatic circulation, reaching the liver and inducing the activation of the nuclear factor kappa-B (NF kappa B) pathway. Pro-inflammatory cytokines released in the process contribute to inflammation and fibrosis. In addition, cellular apoptosis is inhibited in favour of necrosis.
引用
收藏
页数:17
相关论文
共 50 条
  • [41] Role of the Wnt/β-Catenin Pathway in the Pathogenesis of Alcoholic Liver Disease
    Behari, Jaideep
    Sylvester, Karl G.
    CURRENT MOLECULAR PHARMACOLOGY, 2017, 10 (03) : 186 - 194
  • [42] Role of Nutrition in the Pathogenesis and Prevention of Non-alcoholic Fatty Liver Disease: Recent Updates
    Ullah, Rahim
    Rauf, Naveed
    Nabi, Ghulam
    Ullah, Hamid
    Shen, Yi
    Zhou, Yu-Dong
    Fu, Junfen
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2019, 15 (02): : 265 - 276
  • [43] Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes: Pathogenesis and Treatment Options
    Tziomalos, Konstantinos
    Athyros, Vassilios G.
    Karagiannis, Asterios
    CURRENT VASCULAR PHARMACOLOGY, 2012, 10 (02) : 162 - 172
  • [44] Non-Alcoholic Fatty Liver Disease (NAFLD) Pathogenesis and Natural Products for Prevention and Treatment
    Guo, Xiangyu
    Yin, Xunzhe
    Liu, Zuojia
    Wang, Jin
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (24)
  • [45] The combination of blueberry juice and probiotics reduces apoptosis of alcoholic fatty liver of mice by affecting SIRT1 pathway
    Zhu, Juanjuan
    Ren, Tingting
    Zhou, Mingyu
    Cheng, Mingliang
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 1649 - 1661
  • [46] Review: Precision Cut Liver Slices for the Evaluation of Fatty Liver and Fibrosis
    Thiele, Geoffrey M.
    Duryee, Michael J.
    Thiele, Geoffrey E.
    Tuma, Dean J.
    Klassen, Lynell W.
    CURRENT MOLECULAR PHARMACOLOGY, 2017, 10 (03) : 249 - 254
  • [47] Non-alcoholic Fatty Liver Disease: Also a Disease of the Brain? A Systematic Review of the Preclinical Evidence
    Mikkelsen, Anne Catrine Daugaard
    Kjaergaard, Kristoffer
    Mookerjee, Rajeshwar Prosad
    Vilstrup, Hendrik
    Wegener, Gregers
    Bay-Richter, Cecilie
    Thomsen, Karen Louise
    NEUROCHEMICAL RESEARCH, 2024, 49 (06) : 1468 - 1488
  • [48] Molecular mechanism of alcoholic fatty liver
    Rasineni, Karuna
    Casey, Carol A.
    INDIAN JOURNAL OF PHARMACOLOGY, 2012, 44 (03) : 299 - 303
  • [49] Molecular Mechanisms of Alcoholic Fatty Liver
    Purohit, Vishnudutt
    Gao, Bin
    Song, Byoung-Joon
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2009, 33 (02) : 191 - 205
  • [50] Alleviation of Alcoholic Fatty Liver by Dendrobium officinale Flower Extracts due to Regulation of Gut Microbiota and Short-Chain Fatty Acids in Mice Exposed to Chronic Alcohol
    Zhang, Jingchi
    Fan, Jiakun
    Luo, Hui
    Liang, Zhengwei
    Guan, Yanhui
    Lei, Xin
    Bo, Nianguo
    Zhao, Ming
    FOODS, 2023, 12 (07)